Matinas BioPharma Holdings, Inc. (MTNB) Total Assets by Year
Matinas BioPharma Holdings, Inc. closed fiscal year 2025 with $7.2M in total assets, $2.4M in total liabilities and $4.8M in shareholder equity. This represents a decrease of 43.0% from the prior fiscal year. The table below carries 13 fiscal years, from 2013 to 2025, and the quarters Matinas BioPharma Holdings, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
MTNB Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.2M-43.0% | $12.6M-49.6% | $25.1M-44.0% | $44.8M-26.9% | $61.3M-13.6% | $71.0M+76.4% | $40.2M+101.8% | $19.9M+38.3% | $14.4M+46.9% | $9.8M+16.8% | $8.4M+150.1% | $3.4M-70.3% | $11.3M |
| Total Liabilities | $2.4M-52.9% | $5.1M-13.8% | $5.9M-28.4% | $8.2M-7.4% | $8.8M+22.0% | $7.2M+0.7% | $7.2M+89.1% | $3.8M+1.6% | $3.7M+40.3% | $2.7M+14.3% | $2.3M+105.9% | $1.1M+32.0% | $859K |
| Total Equity | $4.8M-36.4% | $7.6M-60.6% | $19.2M-47.5% | $36.6M-30.2% | $52.5M-17.6% | $63.7M+92.8% | $33.1M+104.8% | $16.1M+51.1% | $10.7M+49.4% | $7.1M+17.7% | $6.1M+172.6% | $2.2M-78.7% | $10.5M |
MTNB Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.4M-70.1% | $5.9M-51.2% | $7.2M-43.0% | $9.7M-52.9% | $11.4M-53.1% | $12.0M-38.6% | $12.6M-49.6% | $20.6M-30.9% | $24.4M-28.4% | $19.6M-48.7% | $25.1M-44.0% | $29.8M-37.3% |
| Total Liabilities | $1.6M-57.0% | $2.9M-50.5% | $2.4M-52.9% | $3.2M-32.6% | $3.7M-28.8% | $5.8M+14.1% | $5.1M-13.8% | $4.8M-27.8% | $5.3M-14.7% | $5.1M-10.4% | $5.9M-28.4% | $6.6M-25.6% |
| Total Equity | $1.8M-76.5% | $3.0M-51.8% | $4.8M-36.4% | $6.5M-59.1% | $7.7M-59.8% | $6.3M-56.9% | $7.6M-60.6% | $15.8M-31.8% | $19.1M-31.4% | $14.6M-55.4% | $19.2M-47.5% | $23.1M-40.1% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Matinas BioPharma Holdings, Inc. financials
Frequently Asked Questions
What was Matinas BioPharma Holdings, Inc.'s total assets in fiscal year 2025?
Matinas BioPharma Holdings, Inc. closed fiscal year 2025 with $7.2M in total assets, $2.4M in total liabilities and $4.8M in shareholder equity.
How fast is Matinas BioPharma Holdings, Inc.'s total assets growing?
Matinas BioPharma Holdings, Inc. (MTNB) total assets fell by 43.0% year over year, from $12.6M to $7.2M in fiscal year 2025.
How has Matinas BioPharma Holdings, Inc.'s total assets changed over the years?
Across the 13 fiscal years this page covers, Matinas BioPharma Holdings, Inc. (MTNB) total assets went from $11.3M in fiscal year 2013 to $7.2M in fiscal year 2025.
What was Matinas BioPharma Holdings, Inc.'s total assets in the most recent quarter?
Matinas BioPharma Holdings, Inc. (MTNB) reported $3.4M in total assets in Q2 2026. This represents a decrease of 70.1% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Matinas BioPharma Holdings, Inc. (MTNB) reported on that line in every period on record.